Key Slides: Updated Guidance on HCV Screening and Management in Women

In this downloadable slideset, CCO’s expert faculty reviews how changes in the epidemiology of HCV infection have led to updated guidance on screening during pregnancy and for all individuals in the United States and provides insights on guidelines for HCV care in women, including during pregnancy.
Tatyana Kushner, MD, MSCE
Format: Microsoft PowerPoint (.ppt)
File Size: 1.28 MB
Released: January 8, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Gilead Sciences

Related Content

Clinical Care Options (CCO) expert analysis by Prof Stefan Zeuzem on new viral hepatitis data from EASL 2022, including HBV, HDV, and HCV

Stefan Zeuzem, MD Released: July 6, 2022

Expert selections of important viral hepatitis data from EASL 2022, including studies of patients with HBV, HDV (hepatitis delta virus), and HCV, from Clinical Care Options (CCO)

Tarik Asselah, MD, PhD Stefan Zeuzem, MD Released: July 6, 2022

Clinical Care Options (CCO) podcast with Prof Stefan Zeuzem on key viral hepatitis data from EASL 2022, including HBV, HDV (hepatitis delta), and HCV

Stefan Zeuzem, MD Released: July 6, 2022

Clinical Care Options (CCO) podcast with Dr Nancy Reau on exciting viral hepatitis data from EASL, including HBV, HDV (hepatitis delta), and HCV

Nancy Reau, MD Released: July 5, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings